Prevention and management of VKC in China from the Asian VKC expert consensus
10.3760/cma.j.cn115989-20230628-00027
- VernacularTitle:从亚洲VKC专家共识看我国VKC的防治
- Author:
Xiuming JIN
1
;
Zixuan CAI
;
Ning WANG
Author Information
1. 浙江大学医学院附属第二医院眼科中心，杭州 310009
- Keywords:
Allergic conjunctivitis;
Diagnosis;
Treatment;
Vernal keratoconjunctivitis;
Asia;
Expert consensus
- From:
Chinese Journal of Experimental Ophthalmology
2024;42(2):165-171
- CountryChina
- Language:Chinese
-
Abstract:
The Asian expert working group completed the 2022 consensus on vernal keratitis (VKC), which provides detailed information on the definition, classification, clinical manifestation, diagnosis and treatment of VKC in Asia and identifies unmet treatment needs, including: (1) lack of clear criteria for the diagnosis and treatment of patients with VKC.The pathogenesis of the disease is unclear, and anti-allergy therapy is often ineffective in patients with moderate or severe VKC; (2) the need for standardized treatment and management strategies.Treatment and management of patients with the same severity varies widely among Asian countries, with a lack of clear, standardized guidelines and grading systems; (3) safety and iatrogenic complications; (4) optimal dosing regimen for pharmacologic treatment.In this article, the aspects mentioned above were interpreted and analyzed in the context of the Expert Consensus on the Diagnosis and Treatment of Allergic Conjunctivitis in China ( 2018), with a view to helping the prevention and treatment of VKC in China.
